Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
iv) administered prior to ischaemia confers immediate cardioprotection by recruiting the Gi-protein activation pathway including p38 MAPK
blocking the biosynthesis of the cholesterol fatty acid ester tumour promoter
Smiles: CC(C)N1C=NC2C1=NC(N[C@@H](CO)CC)=NC=2NCC1C=CC(=CC=1)C1=CC=CC=N1
7s)-adamantan-1-yl]naphthalen-2-yl}benzoic acid
Smiles: COC1=CC=C(C=C1O)C1=COC2=CC(O)=CC(O)=C2C1=O
LC3-mHTT-IN-AN2 Catalog No.:M23863-C iv) administered prior to ischaemiaLC3 mHTT IN AN2 (Compound AN2) is a mHTT LC3 linker compound, which interacts with both mutant huntingtin protein (mHTT) and LC3B but not with wtHTT or irrelevant control proteins. LC3 mHTT IN AN2 reduces the levels of mHTT in an allele selective manner in cultured Huntington disease (HD) mouse neurons. Product information CAS Number: 7758 73 8 Molecular Weight: 254. 24 Formula: C15H10O4 Chemical Name: 5,7 dihydroxy 4 phenyl 2H chromen 2 one Smiles:
US$ 35484.00
US$ 58802.00
US$ 2866.50